When it comes to your child, adult research can only tell you so much. At some point, you want to know what the research says about children and teens themselves.
With CurQD®, there are three pieces of pediatric research to explore.
Two looked at CurQD® in younger participants, while a third focused specifically on Qing Dai, one of the botanicals in the formula. Together, they span different research centers, different timeframes and different ways of measuring what happened.
So rather than asking what adult research might tell us, let’s look at what researchers actually found.
CurQD® combines curcumin and Qing Dai in a patented botanical formulation. While both botanicals have been studied independently, the combination itself has also been the subject of research, including research involving children and teens.
One of those studies took place across four pediatric centers in Israel.
30 Young Participants Across Four Pediatric Centers
Researchers followed 30 children and teens whose average age was 14. The study was observational, looking at what had been recorded as part of their care across four pediatric centers.
Researchers used a structured pediatric assessment alongside objective laboratory measures, giving them more than one way to look at what was happening over time.
Participants entered the study with varied histories and prior experience with other forms of care.
During the initial study period, participants’ scores on the study’s structured pediatric assessment improved significantly on average, with 70% (21 of the 30 participants) meeting the study’s predefined benchmark. Among the 12 participants with laboratory results available at both time points, 11 showed improvement in the objective marker researchers were tracking.
The researchers also looked beyond the initial weeks. The initial period lasted approximately 12 weeks, with participants subsequently followed for a median of eight months. That longer view allowed researchers to examine what had been recorded beyond a single short-term check-in.
The doses and ratios of the two CurQD® components varied according to factors including body weight and individual circumstances.
And What About Qing Dai?
There’s another way to look at the formula: zoom in on one of its two botanicals.
Studying Qing Dai on its own gives researchers a more detailed look at one of the components used within the complete CurQD® formulation. A separate peer-reviewed study did exactly that, following 20 children and teens aged 4 to 17 over six weeks.
This study was prospective. In other words, researchers decided in advance what they would measure, when assessments would happen and how participants would be monitored, then followed that plan throughout the study.
Dosing was based on body weight, and researchers used a structured pediatric assessment alongside scheduled laboratory monitoring. Cardiac assessments were performed at the beginning and end of the study, while adverse events were actively monitored from the first few days.
Nineteen of the 20 participants were already following an established care plan when they entered the study.
At the end of the six-week period, 70% (14 of the 20 participants) met the study’s predefined clinical benchmark.
This study looked at Qing Dai rather than the complete CurQD® formulation, so it answers a different question. Alongside the CurQD® research, however, it gives us a closer look at one of the botanicals within the combination.
Another 35 Young People, Followed for 24 Weeks
Another piece of CurQD® research comes from Ann & Robert H. Lurie Children’s Hospital of Chicago.
Researchers followed 35 children and young adults whose regimens included CurQD® in a 24-week real-world analysis. They recorded participants’ reported experiences alongside several objective laboratory measures.
By week 24, 65.5% of participants met the study’s predefined benchmark. Researchers also recorded significant improvements across several objective laboratory measures.
Five participants experienced adverse events, which researchers classified as mild.
The findings were presented in a research poster, adding another perspective to the CurQD® pediatric research: a US-based pediatric setting, another group of younger participants and a 24-week period of observation.
What Happens When You Put the Research Together?
Looking at the three pieces of research together gives us a broader picture.
We have two pieces of pediatric research involving CurQD® itself, across different groups, settings and periods of follow-up. Then we have a separate peer-reviewed prospective study looking specifically at Qing Dai.
They aren’t three versions of the same study, and they shouldn’t be treated as if they are. Each looks at the research from a different angle.
One followed CurQD® across four pediatric centers. Another looked at a different group over 24 weeks in a US children’s hospital. The third zoomed in on Qing Dai itself, with a predefined approach to dosing, assessment and monitoring.
And the headline numbers aren’t the only things researchers recorded. Across the research, pediatric assessments and reported experiences were considered alongside objective laboratory measures. Researchers also documented adverse events and monitored participants over time.
Taken as a whole, that gives us more than one percentage or one set of findings to look at. It gives us three different pieces of pediatric research around CurQD® and its components, each adding a different perspective.
Explore the studies, look at what was measured and monitored, and bring what you learn into the conversation with your healthcare provider.
FAQ
Why is research involving children and teens different from adult research?
Research involving children and teens can take factors such as body weight, age-appropriate assessments and monitoring into account. It also allows researchers to examine findings specifically from younger participants rather than relying on adult research alone.
What pediatric research is covered here?
This article covers three separate pieces of pediatric research: two involving CurQD® and one looking specifically at Qing Dai, one of its botanical components. Together, they include different pediatric settings, research approaches and follow-up periods.
What did researchers monitor beyond how participants said they felt?
Researchers looked at reported experiences alongside objective measures, including laboratory testing. The prospective Qing Dai study also included cardiac assessments at the beginning and end of the study, as well as active monitoring of adverse events.
